A Study to Assess the Recovery and Lifespan of Radiolabeled Autologous S303 Treated Red Blood Cells

NCT01711346 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Focus: Assess Post Infusion Viability of S303 RBCs

Interventions

BIOLOGICAL: S303 Red Blood Cells (RBCs)
BIOLOGICAL: Conventional, untreated Red Blood Cells (RBCs)

Sponsor

Cerus Corporation